Abn Amro Investment Solutions Dr Reddys Laboratories LTD Transaction History

Abn Amro Investment Solutions

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Sep 04, 2025	SELL	$13.99 - $79.75 $57,680 - $328,809	-4,123 Closed	0 $0
Q3 2024 Sep 04, 2025	BUY	$75.41 - $84.21 $310,915 - $347,197	4,123 New	4,123 $328 Million
Q2 2024 Sep 04, 2025	BUY	$68.26 - $76.19 $233,653 - $260,798	3,423 New	3,423 $261 Million
Q1 2024 Sep 05, 2025	BUY	$67.36 - $77.59 $33,680 - $38,795	500 Added 5.89%	8,990 $659 Million
Q4 2023 Sep 05, 2025	SELL	$64.27 - $69.9 $51,416 - $55,920	-800 Reduced 8.61%	8,490 $591 Million

Q3 2023 Nov 07, 2025	BUY	$61.9 - $72.77 $575,051 - $676,033	9,290 New	9,290 $621 Million
Q3 2023 Sep 05, 2025	BUY	$61.9 - $72.77 $575,051 - $676,033	9,290 New	9,290 $621 Million

256

94.4M

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.31B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Abn Amro Investment Solutions, based on Form 13F filings with the SEC.

Stay updated on Abn Amro Investment Solutions with notifications on news.